Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study

Isla S Mackenzie (Lead / Corresponding author), Ian Ford, Andrew Walker, Chris Hawkey, Alan Begg, Anthony Avery, Jaspal Taggar, Li Wei, Allan D Struthers, Thomas M MacDonald, ALL-HEART study group

Research output: Contribution to journalArticle

25 Citations (Scopus)
213 Downloads (Pure)